Randomized phase II cross-over sequential chemotherapy trial of irinotecan/cisplatin (IP) vs. gemcitabine/vinorelbine (GV) in chemo-naive patients with stage IIIb/IV non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Lee, J. S. [1 ]
Lee, D. H. [1 ]
Lee, J. J. [1 ]
Han, J. Y. [1 ]
Park, S. H. [1 ]
Song, J. E. [1 ]
Kim, H. Y. [1 ]
Kim, H. T. [1 ]
机构：
[1] Natl Canc Ctr Hosp, Goyang Gyeonggi, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7134
引用
收藏
页码：397S / 397S
页数：1
相关论文
共 50 条
  • [41] Gemcitabine-cisplatin-vinorelbine phase II trial in stage III non small cell lung cancer
    Cueva, JF
    Grande, C
    Firvida, J
    Amenedo, M
    Lázaro, M
    Romero, C
    Quintero, G
    Huidobro, G
    García, J
    Barón, FJ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S259 - S259
  • [42] Phase I II trial with cisplatin and increasing doses of gemcitabine in stage IV non-small cell lung cancer (NSCLC) diseminado.
    Martínez, J
    Artal, A
    Alonso, V
    Herrero, A
    Maurel, J
    Zorrilla, M
    Puértolas, T
    Ceballos, C
    Antón, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S67 - S67
  • [43] Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study
    S Niho
    K Kubota
    K Goto
    H Ohmatsu
    T Matsumoto
    R Kakinuma
    Yutaka Nishiwaki
    British Journal of Cancer, 2002, 87 : 1360 - 1364
  • [44] A phase II study of 3-week scheduling of irinotecan (I) in combination with cisplatin (P) (revised-IP) in patients with stage IIIB or IV non-small cell lung cancer (NSCLC).
    Saito, H
    Kudoh, S
    Nakagawa, K
    Negoro, S
    Matsui, K
    Senba, H
    Tsukiyama, S
    Takada, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 687S - 687S
  • [45] Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study
    Niho, S
    Kubota, K
    Goto, K
    Ohmatsu, H
    Matsumoto, T
    Kakinuma, R
    Nishiwaki, Y
    BRITISH JOURNAL OF CANCER, 2002, 87 (12) : 1360 - 1364
  • [46] Phase II study of Gemcitabine-vinorelbine (GV) in patients with advanced non-small cell lung cancer (NSCLC) over 70 year-old or with contraindication to receive cisplatin
    Feliu, J
    Lopez-Gomez, L
    Madronal, C
    Jalon, I
    Garcia-Giron, C
    Castro, J
    Martinez, B
    Iglesias, J
    Zamora, P
    Gonzalez-Baron, M
    ANNALS OF ONCOLOGY, 1998, 9 : 85 - 86
  • [47] Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)
    Reinmuth, N.
    Meyer, A.
    Hartwigsen, D.
    Schaeper, C.
    Huebner, G.
    Skock-Lober, R.
    Bier, A.
    Gerecke, U.
    Held, C. -P.
    Reck, M.
    LUNG CANCER, 2014, 83 (03) : 363 - 368
  • [48] A phase II Study of administration of Docetaxel and Vinorelbine with Gemcitabine for inoperable Stage III or IV Non-Small Cell Lung Cancer (NSCLC)
    Reza, Md S.
    Hai, Mohammad A.
    Chowdhury, Qamruzzaman
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S708 - S709
  • [49] Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): Carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel
    Edelman, MJ
    Clark, JI
    Chansky, K
    Albain, K
    Bhoopalam, N
    Weiss, GR
    Giguere, JK
    Kelly, K
    Crowley, J
    Gandara, DR
    CLINICAL CANCER RESEARCH, 2004, 10 (15) : 5022 - 5026
  • [50] Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer
    Isokangas, OP
    Knuuttila, A
    Halme, M
    Mäntylä, M
    Lindström, I
    Nikkanen, V
    Viren, M
    Joensuu, H
    Mattson, K
    ANNALS OF ONCOLOGY, 1999, 10 (09) : 1059 - 1063
12345